Delving into the Latest Updates on Neutec Ar Ge Sanayi Ve Ticaret A S with Synapse

Overview

Tags

Respiratory Diseases

Infectious Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	1

Top 5 Drug Type	Count

Small molecule drug	2

Top 5 Target	Count

mAChRs x β2-adrenergic receptor	1
PBPs x β-lactamase	1

The goal of this clinical trial is to compare the acute bronchodilator effect of pMDI formed Ipratropium / Levosalbutamol 20 mcg / 50 mcg fixed dose combination or pMDI formed Salbutamol 100 mcg Inhaler and Ipratropium 20 mcg Inhalation Aerosol in combination in stable moderate-severe-very severe COPD patients.

Start Date28 Sep 2023

Sponsor / Collaborator

Neutec Ar Ge Sanayi Ve Ticaret A S

NCT05890638 / RecruitingPhase 3

A Randomized, Parallel Group, Phase III, Non-inferiority Study Comparing Ipratropium / Levosalbutamol Fixed Dose Combination and Ipratropium and Levosalbutamol Free Dose Combination Nebuliser Solutions in Stable Chronic Obstructive Pulmonary Disease (COPD)

The goal of this clinical trial is to compare the acute bronchodilator effect of the Ipratropium / Levosalbutamol 1.25 mg & 0.5 mg / 2.5 mL fixed dose combination nebuliser solution or Levosalbutamol 1.25 mg / 3 mL nebuliser solution and Ipratropium 500 mcg nebuliser solution in stable moderate-severe-very severe COPD patients.

Start Date25 Aug 2023

Sponsor / Collaborator

Neutec Ar Ge Sanayi Ve Ticaret A S

NCT03177746 / Unknown statusPhase 4

The Safety of Dapoxetine/Tadalafil Combination Therapy in Treatment of Men With Premature Ejaculation and Erectile Dysfunction

The purpose of this study is to evaluate the safety and efficacy of Dapoxetine/Tadalafil 30/20 mg film-coated tablet in the treatment of men with premature ejaculation and erectile dysfunction.

Start Date31 Dec 2022

Sponsor / Collaborator

Neutec Ar Ge Sanayi Ve Ticaret A S

100 Clinical Results associated with Neutec Ar Ge Sanayi Ve Ticaret A S

Login to view more data

0 Patents (Medical) associated with Neutec Ar Ge Sanayi Ve Ticaret A S

Login to view more data

100 Deals associated with Neutec Ar Ge Sanayi Ve Ticaret A S

Login to view more data

100 Translational Medicine associated with Neutec Ar Ge Sanayi Ve Ticaret A S

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Phase 3 Clinical

1

Approved

Other

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Cefdinir/Clavulanic Acid ( PBPs x β-lactamase )	Respiratory Tract Infections More	Approved
Ipratropium Bromide/Levalbuterol Tartrate ( mAChRs x β2-adrenergic receptor )	Pulmonary Disease, Chronic Obstructive More	Phase 3
Lansoprazole/Domperidone ( D2 receptor x Proton pump )	Gastroesophageal Reflux More	Pending